ABA Home
 

Patent Docs

RSS Feed

This blawg "focuses on recent developments in biotechnology and pharmaceutical patent law. This weblog offers updates regarding changes in patent office rules and procedures that affect biotech/pharma patent prosecution, provides summaries of recent court decisions that impact biotech/pharma patent litigation and prosecution, and monitors newly filed biotech/pharma patent litigation."

Author: Donald Zuhn and Kevin Noonan are partners at McDonnell Boehnen Hulbert & Berghoff in Chicago; Chris Singer and Sherri Oslick are associates at the firm. Jason Derry is an in-house patent attorney.

Blawg Related Categories: Intellectual Property LawPatent LawScience & Technology LawAssociateIn-house LawyerPartner


Recent Posts from Patent Docs

  • LEI National CLE Conference

    Law Education Institute, Inc. (LEI) will be holding the 27th Annual National CLE Conference on January 6-10, 2010 in Vail, Colorado. The Intellectual Property program of the conference, which will be held at the Vail…

  • Amicus Briefs in Ariad v. Eli Lilly: Professor Christopher Holman

    By Kevin E. Noonan -- Christopher M. Holman, Associate Professor of Law at the University of Missouri-Kansas City (and proprietor of Holman's Biotech IP Blog), has filed an amicus brief in support of neither party…

  • Chisum on Patent Law Themes and Inequitable Conduct

    By Donald Zuhn -- Earlier this month, Donald Chisum (at right), who for the past 31 years has authored the patent treatise Chisum on Patents, was in Chicago to give a luncheon presentation on recent…

  • Patent Term Adjustment: 37 C.F.R. § 1.704(b)'s Three-Month Provision

    By Sydney Kokjohn -- Patent practitioners concerned about patent term adjustment should pay careful attention to 37 C.F.R. § 1.704(b) concerning applicant delay, especially regarding the date of issue fee payments. This section provides that…

  • Lilly Files Principal Brief for Ariad v. Lilly Rehearing En Banc

    By Donald Zuhn -- Last week, Defendant-Appellant Eli Lilly & Co. filed its principal brief for the rehearing en banc of Ariad Pharmaceuticals, Inc. v. Eli Lilly & Co., which is scheduled for December 7th.…

  • Court Report

    By Sherri Oslick -- About Court Report: Each week we will report briefly on recently filed biotech and pharma cases, and a few interesting cases will be selected for periodic monitoring. Monsanto Co. et al.…

  • Conference & CLE Calendar

    November 16-17, 2009 - Patent Litigation 2009 (Practising Law Institute) - New York, NY November 17-18, 2009 - Structuring, Negotiating, and Managing Pharma/Biotech Collaborative Agreements (American Conference Institute) - New York, NY November 19, 2009…

  • Panel to Focus on Bilski Oral Argument - Updated

    On Thursday, November 19, 2009, the American University Washington College of Law Program on Information Justice and Intellectual Property and the Federal Circuit Bar Association (FCBA) will be offering a panel discussion entitled "Patentable Subject…

  • If It Ain't Over 'Til It's Over, Today It's Over

    By Kevin E. Noonan -- Chief Judge Paul Michel, writing for most of the en banc Court of Appeals for the Federal Circuit (Judge Lourie took no part in the decision), today granted the joint…

  • USPTO News: Public and Private PAIR Maintenance & Form Usage

    By Christopher P. Singer -- PAIR Maintenance The USPTO posted a message on the front page of PAIR announcing that both Public and Private PAIR will be down for maintenance for part of this weekend.…


Most Read



Latest Featured Blawgs


How to Submit a Blawg

It's really quite easy actually. Just give us the name, URL and RSS feed to the new blawg and we'll add it to the site if it's not already there.

Submit Now!


Return to top